Use and clinical impact of conventional cytotoxic chemotherapy (CTx) subsequent to immunotherapy in metastatic melanoma

被引：1
|
作者：
Malone, E. R. [1 ]
Maltese, M. [1 ]
Coady, L. [1 ]
Hammond, L. [1 ]
Silva, N. [1 ]
Gullo, G. [1 ]
Crown, J. [1 ]
机构：
[1] St Vincents Univ Hosp, Med Oncol, Dublin, Ireland
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw379.45
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1150P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy
    Einzig, AI
    Schuchter, LM
    Recio, A
    Coatsworth, S
    Rodriquez, R
    Wiernik, PH
    MEDICAL ONCOLOGY, 1996, 13 (02): : 111 - 117
  • [32] A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells
    Biteghe, F. A. Nsole
    Davids, L. M.
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2017, 166 : 18 - 27
  • [33] A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma
    Hiniker, S. M.
    Reddy, S. A.
    Maecker, H. T.
    Swetter, S. M.
    Shura, L.
    Knox, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E95 - E95
  • [34] A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma
    Hiniker, Susan M.
    Reddy, Sunil A.
    Maecker, Holden T.
    Subrahmanyam, Priyanka B.
    Rosenberg-Hasson, Yael
    Swetter, Susan M.
    Saha, Saurabh
    Shura, Lei
    Knox, Susan J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (03): : 578 - 588
  • [35] Patient preferences for clinical attributes of metastatic melanoma treatment with targeted therapy and immunotherapy
    Mansfield, Carol
    Ndife, Briana
    Chen, Joyce S.
    Gallaher, Kathleen
    Ghate, Sameer R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Phase I clinical trial of DISC-GMCSF for immunotherapy of metastatic melanoma
    Loudon, PT
    Choolun, E
    Curry, J
    Day, DA
    Duncan, IA
    Entwisle, C
    Lowden, RC
    McLean, CS
    Martin, G
    Shaw, ML
    Gore, M
    Harris, AL
    Ali, SA
    Lynam, J
    Rees, RC
    CANCER GENE THERAPY, 2001, 8 : S24 - S24
  • [37] Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma
    Marshall, Julia A.
    Forster, Trevor H.
    Purdie, David M.
    Lanagan, Catherine M.
    O'Connor, Linda E.
    O'Rourke, Michael GE.
    Johnson, Maree K.
    See, Janet L.
    Ellem, Kay AO.
    Martinez, Nathan R.
    Lopez, J. Alejandro.
    Schmidt, Christopher W.
    IMMUNOLOGY AND CELL BIOLOGY, 2006, 84 (03): : 295 - 302
  • [38] Decreased survival in patients treated by chemotherapy after targeted therapy compared to immunotherapy in metastatic melanoma
    Mangin, Marie-Alix
    Boespflug, Amelie
    Maucort Boulch, Delphine
    Vacheron, Charles-Herve
    Carpentier, Isabelle
    Thomas, Luc
    Dalle, Stephane
    CANCER MEDICINE, 2021, 10 (10): : 3155 - 3164
  • [39] CLINICAL-TRIAL OF COMBINATION CHEMOTHERAPY AND SPECIFIC ACTIVE IMMUNOTHERAPY IN DISSEMINATED MELANOMA
    NEWLANDS, ES
    OON, CJ
    ROBERTS, JT
    ELLIOTT, P
    MOULD, RF
    TOPHAM, C
    MADDEN, FJF
    NEWTON, KA
    WESTBURY, G
    BRITISH JOURNAL OF CANCER, 1976, 34 (02) : 174 - 179
  • [40] ADJUVANT CHEMOTHERAPY (CX) WITH OR WITHOUT IMMUNOTHERAPY (I) FOR MALIGNANT-MELANOMA WITH METASTATIC NODES (MMMN)
    BANZET, P
    JACQUILLAT, C
    MARAL, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 333 - 333
12345